Condition: Acute Lymphoblastic Leukemia, Adult · Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda
This is a multicenter, observational real world clinical trial with prospective follow up that will evaluate the treatment outcome of adolescent and young patients with ph-negative acute lymphoblastic leukemia with first-line pediatric-like protocol in Argentina.
This description comes directly from the study's public registry record.
Luciana Ferrari, Dr. · 541148771000 · lferrari@fundaleu.org.ar
Paula Freigeiro · 5491140470052 · gatla.ar@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto Privado de Hematologia y Hemoterapia | Paraná, Entre Ríos Province, Argentina | Recruiting |
| FUNDALEU | CABA, Argentina | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05127148